Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says
December 05, 2024 at 09:00 AM EST
The jump in prescription fills comes despite limited insurance coverage and high out-of-pocket costs for Novo Nordisk's Wegovy and Eli Lilly's Zepbound.
